|
RNF170 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.886090E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.247000E-01 |
| Normal-vs-Stage2 |
5.972200E-01 |
| Normal-vs-Stage3 |
3.97220000000198E-05 |
| Normal-vs-Stage4 |
3.89459999999842E-05 |
| Stage1-vs-Stage2 |
4.907200E-01 |
| Stage1-vs-Stage3 |
8.12470000000065E-05 |
| Stage1-vs-Stage4 |
8.04970000000127E-05 |
| Stage2-vs-Stage3 |
7.622000E-03 |
| Stage2-vs-Stage4 |
7.524500E-03 |
| Stage3-vs-Stage4 |
9.976200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.637500E-02 |
| Normal-vs-AfricanAmerican |
2.620300E-02 |
| Normal-vs-Asian |
5.045200E-01 |
| Caucasian-vs-AfricanAmerican |
3.958000E-01 |
| Caucasian-vs-Asian |
8.422000E-01 |
| AfricanAmerican-vs-Asian |
9.356800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.203600E-03 |
| Normal-vs-Female |
3.397400E-01 |
| Male-vs-Female |
1.284350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.628200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.056400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.756900E-03 |
| Normal-vs-Age(81-100Yrs) |
7.733600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.045800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.434200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.300800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.516200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.309800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.393200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.913800E-02 |
| Normal-vs-Grade 2 |
8.455400E-01 |
| Normal-vs-Grade 3 |
6.803900E-03 |
| Normal-vs-Grade 4 |
3.1613001105768E-10 |
| Grade 1-vs-Grade 2 |
1.263990E-01 |
| Grade 1-vs-Grade 3 |
4.035100E-03 |
| Grade 1-vs-Grade 4 |
6.16540000053512E-07 |
| Grade 2-vs-Grade 3 |
6.900100E-03 |
| Grade 2-vs-Grade 4 |
4.36769953537919E-10 |
| Grade 3-vs-Grade 4 |
4.42940000000558E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.622100E-02 |
| Normal-vs-ccB subtype |
1.06369999997025E-06 |
| ccA subtype-vs-ccB subtype |
1.23140053709392E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.327980E-01 |
| Normal-vs-N1 |
2.833500E-04 |
| N0-vs-N1 |
9.287600E-02 |
|
|
